Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients. Response

Rev Esp Cardiol (Engl Ed). 2022 Jan;75(1):106. doi: 10.1016/j.rec.2021.08.019. Epub 2021 Oct 19.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • COVID-19*
  • Humans
  • Prognosis
  • SARS-CoV-2

Substances

  • Biomarkers